APP and Alzheimer disease: Total Aβ level and AD pathogenesis are not only dependent on amyloidogenic and non-amyloidogenic APP processing, but rather are determined by additional cellular processes involved in Aβ homeostasis like e.g., gene and protein expression of the Aβ precursor APP, degradation of Aβ peptides and the level of reactive oxygen species (ROS) and of cholesterol.